Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Lonny Levin
Weill Medical Coll of Cornell Univ, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
CEP Biotech
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The work studying the soluble adenylyl cyclase (sAC) covered in this application may serve to increase interest in the study of sAC which would enhance the value of the anti-sAC antibodies sold by CEP Biotech.
Modulating intraocular pressure to treat ocular hypotony and glaucoma
The fluid inside the eye must be maintained at a consistent pressure; pressure that is too high is a fundamental characteristic of glaucoma, while pressure that is too low is called hypotony. If uncorrected, both conditions will cause blindness. Although hypotony is rare, there is no known treatment for it. We have identified a previously unappreciated regulator of pressure in the eye, and we have shown that inhibiting this regulator elevated pressure in a mouse with hypotony. In this grant application, we propose to develop inhibitors of this regulator into first-in-class therapeutics to treat hypotony and test whether activators can treat glaucoma.
Filed on October 12, 2015.
Tell us what you know about Lonny Levin's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Lonny Levin filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Lonny Levin | Weill Medical Coll of Cornell Univ | Conflict of Interest | CEP Biotech, Inc. | $5,000 - $9,999 |
| Lonny Levin | Weill Medical Coll of Cornell Univ | Conflict of Interest | Cutting Edge Pattern (CEP) Biotech | $0 - $4,999 |
| Lonny Levin | Weill Medical Coll of Cornell Univ | Conflict of Interest | CEP Biotech | $0 - $4,999 |
| Lonny Levin | Weill Medical Coll of Cornell Univ | Conflict of Interest | Cutting Edge Pattern (CEP) Biotech | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.